We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- cardiovascular
An SI Board Since May 2001
Posts SubjectMarks Bans
214 29 0
Emcee:  scaram(o)uche Type:  Moderated
scrap book for anything and everything related to the treatment, diagnosis, and prevention of cardiovascular disease

please, to a reasonable degree, try to limit chat. Intended as part file, part high-impact discussion.

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
214Bothell, WA, USA, 23 May 2014: EKOS Corporation, a BTG International group companigel bates-5/23/2014
213SCIPIO: Cardiac Stem Cells Reverse Heart Failure Reed Miller Nov 06, 2012 httrusset-11/7/2012
212MRK dumps MK-0324B: siliconinvestor.comDewDiligence_on_SI-8/9/2012
211What’s New in the Anticoagulant Arena? (updated entries on Semuloparin and PradaDewDiligence_on_SI-6/20/2012
210What’s new in the anticoagulant arena? (first update to compilation since Dec 20DewDiligence_on_SI-6/6/2012
209ThromboGenics’ TB-402 bombs in head-to-head vs Xarelto; this failure was predictDewDiligence_on_SI-6/5/2012
208Advisory panel rejects Xarelto for ACS by 6-4 vote: siliconinvestor.comDewDiligence_on_SI-5/23/2012
207Not All 'Good Cholesterol' Is 'Good': Raising HDL Not a Sure Rouidos-5/17/2012
206<b>Why wine saves some people from heart disease.</b> Resverlogix drusset-4/23/2012
205Effect of Two Intensive Statin Regimens on Progression of Coronary Disease Steprusset-12/5/2011
204By Doug Hornig The first set of findings, from a team at thrusset111/17/2011
203Controversy Over Cholesterol Testing for Children Larry Husten, Contributor sim1-11/12/2011
202Xarelto shocker: 9-2 panel vote in favor of FDA approval.DewDiligence_on_SI-9/8/2011
201Researchers Discover Cellular Process that Clears Cholesterol and Could Reverse russet19/8/2011
200(related to a sidelined project from arna)........... J Cardiovasc Pharmacol. scaram(o)uche-8/10/2011
199JNJ pulls out of drug-eluting-stent business: siliconinvestor.comDewDiligence_on_SI-6/15/2011
198NVS, Portola Advance Elinogrel to Phase-3: siliconinvestor.comDewDiligence_on_SI-8/30/2010
197<b>How Large Is the Anticoagulant Market?</b> siliconinvestor.comDewDiligence_on_SI-6/13/2010
196Big win for Apixaban in stroke prevention secondary to atrial fib: siliconinvesDewDiligence_on_SI16/11/2010
195In addition to my previous reply, I think that by new potential molecular targetidos-4/29/2010
194Yes, Zetia's mechanism for lowering LDL levels is different from the statinsidos-4/29/2010
193<i>>Statins reduce the synthesis of endogenous…cholesterol and diminishDewDiligence_on_SI-4/29/2010
192On the pathogenesis of atherosclerosis - cholesterol crystals activate inflammasidos-4/29/2010
191Miscellaneous clinical data from ACC conference today… MRK/Portola Report PhaseDewDiligence_on_SI-3/15/2010
190ABT’s TriCor Does Not Benefit Most Diabetics: siliconinvestor.comDewDiligence_on_SI-3/15/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):